Astragalus: the herb, the trials, and the gap between them

Astragalus (Astragalus membranaceus, 黄芪 huáng qí) is the herb that appears in more supplement marketing than any other in this tradition, usually under the phrase “immune support”. It is also one of the few herbs here with a genuine pharmacological literature. The two facts are related and they have been badly tangled.

What the texts actually claim

The Shennong Bencao Jing lists it in the upper class, and the entry is not what a modern reader expects. The indications given are mostly external — chronic ulceration, abscesses, fistulas, haemorrhoids — alongside 补虚, “tonify vacuity”, and a line about children’s diseases. The association with the lung and with defensible qi, the 卫气 that keeps things out, comes later and gets systematised in the Song and Jin commentaries.

This matters for reading modern claims. “Astragalus for immunity” is not a classical statement. It is a twentieth-century compression of a later theoretical development, and the compression dropped the parts that made the original coherent — that it was used for slow-healing tissue, for what would now be called wound repair and chronic inflammation, long before it was used for infection.

What is in it

The constituents that get studied are the polysaccharides, the saponins (astragaloside IV is the marker compound on most HPLC assays), and the flavonoids. Note the structure of that sentence: an assay measures astragaloside IV because it is easy to measure, not because it is the active constituent. A root with a good astragaloside number can be a poor root, and the two are routinely conflated on certificates of analysis.

What the trials show

There is a large volume of clinical work, most of it Chinese, much of it using an injectable form that is not sold as a supplement anywhere else. The recurring pattern in the meta-analyses:

• Effects are reported as adjunctive — added to conventional treatment rather than compared against it.
• The included trials are usually small, single-centre, and of short duration.
• Allocation concealment and blinding are frequently unclear, which is a polite way of saying the results should be discounted.
• Several of the more promising areas use the injection, which tells you nothing about a capsule.

None of this means the herb does nothing. It means the honest summary is “plausible, weakly evidenced, and not established”, and that is a different sentence from the one on the bottle.

Safety, which is the part people skip

Astragalus is a food-grade herb with a long history and a low rate of adverse events, and for most people that is the end of the story. Three exceptions are worth stating plainly:

1. Autoimmune disease and immunosuppression. The traditional use is as an immunostimulant, and there is a theoretical argument that it works against drugs given to suppress immune activity. Theoretical is not proven, but if you are on a calcineurin inhibitor or on biologics, this is a conversation to have with your prescriber rather than a decision to make from a website.
2. Anticoagulants. There are case reports of increased bleeding tendency, and the mechanism is not settled. Low risk, non-zero, and relevant if you are already at the borderline.
3. Pregnancy and transplant. Not enough data, and in the transplant case a plausible mechanism for harm.

How we would use it

As a decoction herb in a formula, at classical proportions, for the presentations it was actually indicated for — poor healing, chronic low-grade depletion, sweating with weakness. Not as a daily capsule taken indefinitely on the grounds that it is “good for immunity”, which is a claim no supplement has ever supported and which the herb’s own tradition does not make.

The reference page for the pattern this herb belongs to is qi deficiency, which is the pattern the classical indications actually point at — and which, unlike “low immunity”, has a defined set of signs.

• qi deficiency
• immunology
• drug interactions